Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nutriband Inc. stock logo
NTRB
Nutriband
$3.49
-1.3%
$3.75
$3.21
$11.68
$42.38M1.912,103 shs4,496 shs
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$3.88
+3.3%
$6.01
$0.75
$8.50
$46.66M-0.0846,222 shs14,843 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.78
+3.0%
$3.69
$2.66
$5.92
$45.74M1.0981,590 shs29,770 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$0.48
-5.0%
$0.60
$0.44
$3.45
$11.86M0.31321,117 shs325,508 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nutriband Inc. stock logo
NTRB
Nutriband
-1.26%-0.56%-5.87%-10.18%-54.69%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-1.32%-15.54%-46.58%-36.55%+374.68%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+0.37%-4.93%-12.34%-34.15%-46.00%
SurgePays, Inc. stock logo
SURG
SurgePays
0.00%-10.17%-9.91%-43.18%-81.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nutriband Inc. stock logo
NTRB
Nutriband
$3.49
-1.3%
$3.75
$3.21
$11.68
$42.38M1.912,103 shs4,496 shs
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$3.88
+3.3%
$6.01
$0.75
$8.50
$46.66M-0.0846,222 shs14,843 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.78
+3.0%
$3.69
$2.66
$5.92
$45.74M1.0981,590 shs29,770 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$0.48
-5.0%
$0.60
$0.44
$3.45
$11.86M0.31321,117 shs325,508 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nutriband Inc. stock logo
NTRB
Nutriband
-1.26%-0.56%-5.87%-10.18%-54.69%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-1.32%-15.54%-46.58%-36.55%+374.68%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+0.37%-4.93%-12.34%-34.15%-46.00%
SurgePays, Inc. stock logo
SURG
SurgePays
0.00%-10.17%-9.91%-43.18%-81.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nutriband Inc. stock logo
NTRB
Nutriband
1.50
ReduceN/AN/A
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
2.00
HoldN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.57
Moderate Buy$6.88152.02% Upside
SurgePays, Inc. stock logo
SURG
SurgePays
1.67
Reduce$3.50629.17% Upside

Current Analyst Ratings Breakdown

Latest SURG, SRTS, QTI, and NTRB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/10/2026
SurgePays, Inc. stock logo
SURG
SurgePays
Lower Price TargetBuy$5.00 ➝ $3.50
6/3/2026
Nutriband Inc. stock logo
NTRB
Nutriband
UpgradeSell (E+)Sell (D-)
5/22/2026
SurgePays, Inc. stock logo
SURG
SurgePays
Reiterated RatingSell (E+)
5/15/2026
SurgePays, Inc. stock logo
SURG
SurgePays
DowngradeHoldStrong Sell
5/8/2026
Nutriband Inc. stock logo
NTRB
Nutriband
Reiterated RatingSell (E+)
5/8/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
4/21/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingSell (D)
4/20/2026
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
UpgradeStrong SellHold
4/17/2026
SurgePays, Inc. stock logo
SURG
SurgePays
Lower Price TargetBuy$9.75 ➝ $5.00
(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nutriband Inc. stock logo
NTRB
Nutriband
$2.04M21.01N/AN/A$0.55 per share6.41
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$18.92M2.47N/AN/A$0.54 per share7.19
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M1.63N/AN/A$2.93 per share0.93
SurgePays, Inc. stock logo
SURG
SurgePays
$56.96M0.21N/AN/A($0.66) per share-0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nutriband Inc. stock logo
NTRB
Nutriband
-$8.23M-$2.60N/AN/AN/A-403.98%-118.33%-101.92%N/A
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-$21.08M-$1.24N/AN/AN/A-58.93%-4,220.38%-51.77%8/6/2026 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.47N/AN/AN/A-34.50%-15.79%-14.02%8/6/2026 (Estimated)
SurgePays, Inc. stock logo
SURG
SurgePays
-$36.07M-$1.94N/A8.00N/A-64.91%-967.32%-310.16%8/12/2026 (Estimated)

Latest SURG, SRTS, QTI, and NTRB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2026Q4 2025
SurgePays, Inc. stock logo
SURG
SurgePays
-$0.19-$0.51-$0.32-$0.51$15.50 million$15.98 million
5/13/2026Q1 2026
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-$0.1350-$0.25-$0.1150-$0.25$6.45 million$6.53 million
5/7/2026Q1 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.16-$0.0350-$0.16$5.32 million$3.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
SurgePays, Inc. stock logo
SURG
SurgePays
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
6.36
6.21
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
1.38
2.49
1.69
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
7.27
4.03
SurgePays, Inc. stock logo
SURG
SurgePays
N/A
0.27
0.26

Institutional Ownership

CompanyInstitutional Ownership
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
24.19%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
SurgePays, Inc. stock logo
SURG
SurgePays
6.94%

Insider Ownership

CompanyInsider Ownership
Nutriband Inc. stock logo
NTRB
Nutriband
52.21%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
28.80%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
SurgePays, Inc. stock logo
SURG
SurgePays
29.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nutriband Inc. stock logo
NTRB
Nutriband
1012.16 million5.81 millionNot Optionable
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/A12.04 million8.57 millionN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.46 million14.78 millionOptionable
SurgePays, Inc. stock logo
SURG
SurgePays
4025.12 million17.81 millionOptionable

Recent News About These Companies

SurgePays, Inc. Q4 2025 Earnings Call Summary
SurgePays, Inc. (SURG) Q4 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Nutriband stock logo

Nutriband NASDAQ:NTRB

$3.48 -0.05 (-1.27%)
As of 01:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

QT Imaging stock logo

QT Imaging NASDAQ:QTI

$3.88 +0.13 (+3.33%)
As of 02:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$2.78 +0.08 (+2.96%)
As of 02:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

SurgePays stock logo

SurgePays NASDAQ:SURG

$0.48 -0.03 (-5.00%)
As of 02:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.